These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35007329)

  • 1. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Boyko EJ; Zelnick LR; Braffett BH; Pop-Busui R; Cowie CC; Lorenzi GM; Gubitosi-Klug R; Zinman B; de Boer IH
    Diabetes Care; 2022 Feb; 45(2):357-364. PubMed ID: 35007329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
    Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
    Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Prior Intensive Insulin Therapy and Risk Factors on Patient-Reported Visual Function Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Cohort.
    ; Gubitosi-Klug RA; Sun W; Cleary PA; Braffett BH; Aiello LP; Das A; Tamborlane W; Klein R
    JAMA Ophthalmol; 2016 Feb; 134(2):137-45. PubMed ID: 26584339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Martin CL; Albers JW; Pop-Busui R;
    Diabetes Care; 2014; 37(1):31-8. PubMed ID: 24356595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with diabetic foot ulcers and lower limb amputations in type 1 and type 2 diabetes supported by real-world data from the German/Austrian DPV registry.
    Eckert AJ; Zimny S; Altmeier M; Dugic A; Gillessen A; Bozkurt L; Götz G; Karges W; Wosch FJ; Kress S; Holl RW;
    J Diabetes; 2024 Feb; 16(2):e13531. PubMed ID: 38403299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    de Boer IH;
    Diabetes Care; 2014; 37(1):24-30. PubMed ID: 24356594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study.
    Albers JW; Herman WH; Pop-Busui R; Feldman EL; Martin CL; Cleary PA; Waberski BH; Lachin JM;
    Diabetes Care; 2010 May; 33(5):1090-6. PubMed ID: 20150297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP; Gao X; Bebu I; Das A; Olmos de Koo L; Barkmeier AJ; Tamborlane W; Lachin JM; Aiello LP;
    Ophthalmology; 2021 Apr; 128(4):554-560. PubMed ID: 32941962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
    Genuth S
    Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Braffett BH; Gubitosi-Klug RA; Albers JW; Feldman EL; Martin CL; White NH; Orchard TJ; Lopes-Virella M; Lachin JM; Pop-Busui R;
    Diabetes; 2020 May; 69(5):1000-1010. PubMed ID: 32051148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
    Pop-Busui R; Braffett BH; Zinman B; Martin C; White NH; Herman WH; Genuth S; Gubitosi-Klug R;
    Diabetes Care; 2017 Jan; 40(1):94-100. PubMed ID: 27803120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
    White NH; Cleary PA; Dahms W; Goldstein D; Malone J; Tamborlane WV;
    J Pediatr; 2001 Dec; 139(6):804-12. PubMed ID: 11743505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Neuropathy, Glycemic Control, and Revascularization as Risk Factors for Future Lower Extremity Amputation among Diabetic Patients.
    Goldman MP; Corriere MA; Craven T; Davis RP; Sheehan M; Hurie JB; Velazquez G; Williams TK; Chang K; Edwards MS
    Ann Vasc Surg; 2021 May; 73():254-263. PubMed ID: 33248240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    Lachin JM; Orchard TJ; Nathan DM;
    Diabetes Care; 2014; 37(1):39-43. PubMed ID: 24356596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and risk factors of lower extremity amputation in the diabetic inpatients with foot ulcers.
    Gong H; Ren Y; Li Z; Zha P; Bista R; Li Y; Chen D; Gao Y; Chen L; Ran X; Wang C
    Front Endocrinol (Lausanne); 2023; 14():1144806. PubMed ID: 37065766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome and determinants of amputation in a large cohort of Iranian patients with diabetic foot ulcers.
    Niakan MH; Dehghankhalili M; Pourdavood A; Vahidi A; Nazemi S; Piranviseh A; Hasanvand K
    Foot (Edinb); 2020 Dec; 45():101688. PubMed ID: 33011496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study.
    Hainsworth DP; Bebu I; Aiello LP; Sivitz W; Gubitosi-Klug R; Malone J; White NH; Danis R; Wallia A; Gao X; Barkmeier AJ; Das A; Patel S; Gardner TW; Lachin JM;
    Diabetes Care; 2019 May; 42(5):875-882. PubMed ID: 30833368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.